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Summary 
We have identified, by affinity chromatography, a bind- 
ing protein for the snake venom toxin taipoxin. The 
sequence of this 47 kDa protein is unique, is character- 
istic of a secreted protein, and has homology to the 
acute phase proteins serum amyloid P protein and 
C-reactive protein of the pentraxin family. We have 
named this protein neuronal pentraxin (NP), as North- 
ern analysis and in situ hybridization demonstrate high 
message levels in neurons of cerebellum, hippocam- 
pus, and cerebral cortex. Because NP may be released 
synaptically and has homology to immune proteins po- 
tentially involved in uptake of lipidic, toxic, or other 
antigenic material, we suggest that NP may be in- 
volved in a general uptake ef synaptic macromole- 
cules. 
Introduction 
Presynaptic acting snake venom toxins block neuromus- 
cular transmission and are some of the most lethal toxins 
known (Lee, 1979). We are investigating the actions of 
one of the most potent of these toxins, taipoxin (LDso of 
2 I~g/kg in mice; Kamenskaya and Thesleff, 1974), with 
the idea that receptors for this toxin may be functionally 
important components of presynaptic terminals. Taipoxin 
blocks neuromuscular transmission with a latency of one 
to several hours without affecting muscle sensitivity to ace- 
tylcholine. Taipoxin causes a loss of synaptic vesicles at 
neuromuscular junctions and the appearance of numer- 
ous omega figures in the presynaptic nerve terminal mem- 
brane (Cull-Candy et al., 1976). The three subunits of tai- 
poxin, like most presynaptic acting snake venom toxins, 
have sequence homology to secretory phospholipase A2s 
(Dufton and Hilder, 1983). Taipoxin requires calcium to 
block neurotransmission (Strong, 1987) and is blocked by 
modifying reagents that inactivate phospholipase A2 activ- 
ity (Fohlman et al., 1979). Although this suggests that the 
lethality of taipoxin is related to phospholipid hydrolysis, 
taipoxin has very low phospholipase activity as a multimer 
(Lee, 1979). This paradox has lead to the suggestion that 
taipoxin first binds to or gains entry to the presynaptic 
terminal and is subsequently activated (Strong, 1987). 
Cross-linking studies have suggested the existence of a 
45 kDa high affinity neuronal receptor for taipoxin (Tzeng 
et al., 1989). Here, we report the purification of 47 kDa 
and 49 kDa taipoxin-binding proteins by affinity chroma- 
tography of solubilized rat brain membranes on a column 
of immobilized taipoxin. Molecular analysis of cDNA 
clones coding for the 47 kDa protein reveals that it is a 
novel nervous system protein with homology to the se- 
creted acute phase proteins C-reactive protein (CRP; 
Whitehead et al., 1990) and serum amyloid P protein 
(SAMP; Dowton and McGrew, 1990). As such, we have 
named this protein neuronal pentraxin. The production of 
this protein by neurons, its uptake by glia, and its potential 
synaptic release suggest that this protein may mediate a 
novel neuronal function. 
Results 
Affinity Chromatography Identifies 
Taipoxin-Binding Proteins 
The high lethality of taipoxin suggests that it binds to spe- 
cific neuronal proteins with high affinity. This raises the 
possibility of using immobilized taipoxin to purify such neu- 
ronal proteins from solubilized brain membranes. We in- 
vestigated conditions for coupling taipoxin that retained 
its activity. We have found that incubation of cultured hip- 
pocampal neurons with taipoxin at concentrations as low 
as 20-50 pM effectively blocks synaptic vesicle recycling 
within 20-60 min, causing presynaptic terminal swelling 
and cell surface exposure of synaptic vesicle proteins, as 
assayed by fluorescence microscopy using antibody to 
the lumenal domain of synaptotagmin (Perin et al., 1991; 
Matteoli et al., 1992; Perin et al., unpublished data). Tai- 
poxin was conjugated with carboxymethylrhodamine suc- 
cinimide ester at different pHs, purified, and added to neu- 
rons. Rhodamine-taipoxin conjugated at pH 8.7 was 
inactive. Coupling at pH 7.0 resulted in toxin as active as 
native taipoxin (data not shown). We used this pH to couple 
taipoxin to activated CH-Sepharose (Pharmacia). 
For chromatography, rat brains were homogenized in 
isotonic sucrose and centrifuged to obtain a crude brain 
membrane fraction. Solubilized rat brain membranes were 
chromatographed on a column of immobilized taipoxin in 
the presence of 100 mM NaCI and 1 mM free calcium to 
mimic extracellular ionic conditions. The column was first 
eluted with 10 mM EDTA and followed with a second elu- 
tion with 1 M NaCI. We chose to elute with EDTA because 
taipoxin requires calcium to block neurotransmission 
(Strong, 1987). Elution with EDTA yielded two major pro- 
teins of apparent molecular weight of 47 and 49 kDa (Fig- 
ure la). Further elution with 1 M NaCI yielded no further 
proteins. The purification of these proteins is specific to 
the taipoxin column, as 47 and 49 kDa proteins are not 
enriched by similar chromatography on ethanolamine- or 
synaptotagmin-conjugated CH-Sepharose (data not shown). 
Structure of 47 kDa Taipoxin-Binding Protein 
The 47 and 49 kDa proteins were separated by ion ex- 
change chromatography and separately treated with cy- 
anogen bromide (CNBr). Partial sequences of three sepa- 
rate peptides of the 47 kDa protein were determined (41, 
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Figure 1. Proteins of 47 and 49 kDa Are 
Greatly Enriched by Calcium-Dependent Chro- 
matography on Columns of Immobilized Tai- 
poxin 
(a) Chromatography of Triton X-100 solubilized 
rat brain membranes on a column of immobi- 
lized taipoxin was as described in Experimen- 
tal Procedures. $olubilized brain membrane 
(SM; 50 I~g), column flow through (FT; 50 ~g), 
first EDTA eluate (El; 5 I~g), and high salt sec- 
ond eluate (E2; 5 I~g) were run on a 10% SDS- 
PAGE gel and Coomassie stained. 
(b) Western blot analysis demonstrates that NP 
is not an abundant protein and is greatly en- 
riched by chromatography on columns of im- 
mobilized taipoxin. Solubilized brain mem- 
branes (SM; 50 p,g), column flow through (FT; 
50 ~g), first EDTA eluate (El ; 5 p,g), high salt 
second eluate (E2; 5 ~g), and brain cytosol 
(CYT; 50 ~g) were run on a 100/o SDS-PAGE 
gel, transferred to nitrocellulose membranes, 
and immunoblotted with four separate NP anti- 
bodies: NP1, an antibody to a bacterially pro- 
duced recombinant portion f NP (residues 
292-415); N P2, an amino-terminal antipeptide 
antibody (residues 42-57); NP3, an antibody t  
recombinant NP (residues 21-432); and NP4, a 
carboxyl-terminal antipeptide antibody (resi- 
dues 419-432). 
(c) Deglycosylation of NP by endoglycosidase 
F/glycopeptidase F yields protein of the same 
molecular size as recombinant NP lacking sig- 
nal peptide. Purified NP was incubated over- 
night at 37°C in the presence (NP/endoF) or 
absence (NP-o/n) of a mixture of endogly- 
cosidase F/glycopeptidase F. An equivalent 
amount of native NP or recombinant NP (rNP, 
residues 21-432) were used as controls. Sam- 
ples were denatured with SDS sample buffer 
and run on SDS-PAGE gels, transferred to ni- 
trocellulose sheets, and blotted with NP1 anti- 
body. 
35, and 45 amino acids, respectively; Figure 2). Degener- 
ate oligonucleotides coding for pieces of individual peptide 
sequences were synthesized, end-labeled with 32p, and 
used to screen a rat brain cDNA library. Two overlapping 
cDNA clones were found to contain cDNA sequence cod- 
ing for the peptides derived from the 47 kDa protein. Simi- 
larly, separate cDNA clones were identified that code for 
the 49 kDa protein. The message for the 49 kDa protein 
was present in all tissues tested (see Figure 4; Dodds et 
al., 1995). cDNA sequencing revealed that the 49 kDa 
protein contains a signal sequence, six EF hand calcium- 
binding domains, and a carboxyl-terminal H DEL sequence 
identical to a yeast endoplasmic reticulum targeting se- 
quence (Dodds et al., 1995). Antibodies to the 49 kDa 
protein revealed a reticular staining pattern in neurons, 
glia, and presumably all cells. In neurons, staining for the 
49 kDa protein extended into all neuronal processes 
(Dodds et al., 1995). 
The nucleotide and deduced amino acid sequence of the 
47 kDa protein as derived from two cDNAs (pTA7 residues 
1195-5354, pTAL14 residues 1-2190) is shown in Figure 
2. The composite cDNA is 5354 nucleotides long con- 
taining a short 5'-untranslated sequence, a 1.6 kb open 
reading frame, and a long 3.5 kb 3'-untranslated se- 
quence. The deduced amino acid sequence contains no 
regions conducive to forming a membrane-spanning se- 
quence as determined by hydropathy analysis (Kyte and 
Doolittle, 1982). Near the putative amino terminus, the 
sequence contains a stretch of 10 hydrophobic residues 
suggestive of a signal sequence (von Hiejne, 1986). This 
amino acid stretch is unusual in that it follows the third 
methionine from the in-frame stop codon at nucleotide 
288. Assuming cleavage after this apparent signal se- 
quence, the 47 kDa taipoxin-binding protein would have 
a calculated molecular weight of 45 kDa. The deduced 
amino acid sequence also contains the sequences NSS 
and NDT for N-linked glycosylation at residues 154 
and 193. 
47 kDa Protein Is Homologous to Acute Phase 
Proteins of the Pentraxin Family 
Searches of GenBank and SWlSS-PROT databases re- 
vealed that this is a novel protein. The 47 kDa protein 
shares amino acid sequence homology (20%-30% iden- 
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Figure 2. Nucleotide and Translated Amino Acid Sequences of Mes- 
sage for NP 
The sequences are numbered to the right, with the translated amino 
acid sequence being shown in single-letter code below the nucleotide 
sequence. The amino acid sequences obtained from protein fragments 
of a CNBr digest are underlined. In-frame stop codons in the 5' and 
3' ends of the cDNA are also underlined. The deduced amino acid 
sequence is shown from the first meth onine after the 5' stop codon. 
The third methionine after the 5'stop codon is boxed and is the proba- 
ble initiator methionine, as it is in front of a putative signal sequence 
(dashed underline). 
tity) with proteins of the pentraxin family (Figure 3). This 
family includes the acute phase proteins CRP (Whitehead 
et al., 1990) and SAMP (Dowton and McGrew, 1990), as 
well as female-specific protein (FP; Dowton and Wag- 
goner, 1989) and human pentaxin 3 (PTX3; Breviario et al., 
1992). The 47 kDa protein's homology to other pentraxins 
places it as a more distant member of this family. This is 
evident in size alone, as CRP, SAMP, and FP are half the 
size of the 47 kDa protein. PTX3 is longer than the other 
pentraxins but is still smaller than the 47 kDa protein. The 
carboxyl end of the 47 kDa protein (residues 244-432) 
exhibits homology to CRP and SAMP, but the homology 
to PTX3 extends amino-terminal beyond this half. This 
homology includes identity to domains of CRP implicated 
in calcium binding (38% identity with residues 169-189 of 
mouse CRP) and phosphorylcholine binding (29% identity 
with residues 47-85 mouse CRP; Agrawal et al., 1993). 
The 20%-30% identity between the 47 kDa protein and 
CRP or SAMP over a similar region of protein is much 
lower than homology between other pairs of pentraxins, 
such as SAMP and CRP (approximately 50% identical). 
Comparing all proteins together, there is 11% identity over 
the carboxyl-terminal residues of the 47 kDa taipoxin- 
binding protein. 
Message for 47 kDa Taipoxin-Binding Protein 
(Neuronal Pentraxin) 
Northern analysis reveals an -5 .5  kb message for the 47 
kDa taipoxin binding protein that is expressed in brain and 
cerebellum (Figure 4). Given the homology of this protein 
to the pentraxins and its brain distribution, we propose to 
name this protein neuronal pentraxin (NP). Message for 
NP is fairly abundant, as an 18 hr exposure is sufficient 
to reveal hybridization of oligonucleotide and cDNA 
probes to Northern blots. Message for NP could not be 
detected in heart, skeletal muscle, liver, or kidney even 
when Northern blots were exposed for 6 days. A low abun- 
dance message of 2.5 kb was detected in testis with both 
cDNA and oligonucleotide probes. As shown in the bottom 
panel, message coding for the 49 kDa protein was found 
in all tissues. 
In Situ Hybridization of NP Message 
We examined, by in situ hybridization, the expression of 
NP message in adult rat brain. Hybridization signal is local- 
ized to neurons. As shown in Figure 5, cRNA probes hy- 
bridize to Purkinje and granule cell layers of cerebellum 
(Figure 5a), to cortex (Figure 5b), and to hippocampus 
(Figure 5c), as well as medial habenula (Figure 5c), ante- 
rior hypothalamic nuclei (data not shown), and inferior oli- 
vary nuclei (Figure 5g). The highest hybridization is pres- 
ent in granule and Purkinje neurons. Strong hybridization 
is also present in the CA3 region of hippocampus. The 
hilus and dentate gyrus shows moderate hybridization, 
whereas the CA1 shows detectable but low hybridization. 
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Figure 3. Alignment of the Sequence of NP 
with Four Members of the Pentraxin Protein 
Family 
The sequences are numbered on the right as 
in Figure 2 (Dowton and McGrew, 1990; 
Whitehead et al., 1990; Dowton and Wag- 
goner, 1989; Breviario et al., 1992). Residues 
that are identical between pentraxin family 
members and NP are boxed. The putative sig- 
nal peptide of each protein is shown in dashed 
underline. 
SAMP rat, serum amyloid P protein; CRP 
mouse, C-reactive protein; FP hamster, female 
protein; PTX3 human, pentaxin 3. 
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Figure 4. RNA Blot Analysis of Message for NP in Rat Tissues 
Poly (A)÷-enriched RNA (5 p.g) from rat brain, cerebellum, kidney, testis, 
liver, spleen, heart, skeletal muscle, as well as the rat neurosecretory 
cell line PC12 were electrophoresed, blotted, and probed with an oligo- 
nucleotide complementary to the NP cDNA sequence (nucleotides 
1281-1262). The top right panel is a 6 day autoradiographic exposure, 
the top left, 18 hr. The numbers to the right indicate positions of RNA 
size standards in kilobases (kb). The bottom panel shows the hybridiza- 
tion of the same Northern to an antisense cDNA probe for the message 
of the 49 kDa protein. 
The difference in hybridization between the CA3 and CA1 
regions of the hippocampus is even more dramatic given 
the higher neuronal density in CAl. Hybridization in the 
cortex is apparently highest in the visual cortex (Figure 
5b). This hybridization is strongest in layer 6, but is present 
in other layers. In addition, there is moderate signal in 
layer 2 of the olfactory cortex (Figure 5f). White matter is 
uniformly negative, and there is no evidence of hybridiza- 
tion in glia. The lack of glial hybridization in gray matter 
is shown in Figures 5b and 5d. At high power (Figure 5d), 
it is clear that hybridization signal only surrounds large 
neuronal nuclei and not the smaller glial nuclei. 
Ant ibody  to NP  
To study the distribution of NP protein, we raised four 
antibodies to N P that recognize different segments of the 
protein. As shown in Figure 1, all four NP antibodies recog- 
nize the same 47 kDa protein in Western blots. The protein 
is rare, as it is not easily detected in brain homogenates, 
brain membranes, synaptic vesicles (data not shown), or 
brain cytosol, but can be detected after affinity purification. 
These specific antibodies allowed us to demonstrate that 
NP is enriched on taipoxin columns at least 1000-fold. 
Though 100 ng eluate (El) is easily detectable on Western 
blots with NP antibodies, the same antibodies fail to detect 
NP in 100 p.g of solubilized membranes or cytosol (data 
not shown). The low protein abundance of NP contrasts 
with the relative abundance of NP message in brain. This 
must either reflect a high rate of turnover of the protein 
or a low rate of translation. 
NP antibodies and a recombinant putatively full-length 
NP were used to investigate the potential glycosylation 
of NP. Bacteria were transformed with an NP expression 
plasmid encoding residues 21-432 to initiate after the pu- 
tative signal peptide. These cells synthesize a protein of 
approximately 43 kDa (see Figure lc). Native NP has an 
apparent molecular weight of 47 kDa. Cleavage of native 
NP with endoglycosidase F/glycopeptidase F yields pro- 
tein with the same molecular size as recombinant NP, 
demonstrating that NP is glycosylated, that the proposed 
signal peptide is cleaved, and that the third methionine 
from the 5' stop codon is the initiator methionine. 
Ta ipox in  Causes  Gl ia l  Death  when Added wi th  NP  
Taipoxin at 20 pM blocks synaptic vesicle recycling in 20 
min to 1 hr and kills cultured hippocampal neurons within 
3-12 hr. Many cell lines, including COS-7 and CHO cells, 
are insensitive to taipoxin, as they survive and divide for 
at least 5 days in 1 I~M taipoxin with no apparent effects. 
Immunocytochemistry suggests glial uptake of NP (data 
not shown). This raises the issues of whether taipoxin is 
toxic to glial cells and whether NP is involved in toxicity. 
We tested this with rat brain gila cultured in the absence 
of neurons. The results of addition of taipoxin or addition 
of combinations of taipoxin with NP, recombinant NP, or a 
recombinant control protein (synaptotagmin residues 78- 
263) are shown in Table 1. Three trials for each condition 
were performed. Purified NP was added to 10 nM. Eluate 
1 was added to give 10 nM NP. Recombinant NP and 
taipoxin were added after mixing and removal of insoluble 
material by centrifugation, yielding recombinant NP of less 
than 10 nM. For a control, a recombinant piece of synapto- 
tagmin was added to 10 nM. Cell death was checked after 
12 hr (plus was scored if greater than one quarter of the 
glia were dead). As shown in Table 1, NP greatly lowered 
the concentration of taipoxin capable of causing glial death 
(1-10 nM compared with 10-100 nM), suggesting that N P 
greatly enhances the glial toxicity of taipoxin. 
Discuss ion  
We have identified a novel neuronal protein, which we 
have named neuronal pentraxin, that is highly purified by 
chromatography on immobilized taipoxin. NP is neuronally 
expressed, with the highest levels of message being found 
in cerebellum and CA3 region of the hippocampus. Our 
ideas of the potential in vivo function of this protein are 
based on data indicating that it is neuronally produced, 
is evidently secreted, may be turned over rapidly, has ho- 
mology to acute phase proteins of the pentraxin family, 
and may mediate the neuronal and glial uptake of the 
snake venom toxin taipoxin. 
Northern analysis and in situ hybridization clearly show 
that NP is produced by neurons. NP message is expressed 
at high levels in Purkinje and granule neurons of the cere- 
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Figure 5. Distribution of NP Message in Brain Sections Revealed by In Situ Hybridization 
Representative 7 ~m sections of rat brain were hybridized to [:~S]UTP-labeled NP-riboprobes as outlined in Experimental Procedures. Hybridization 
(detection of silver gains in the emulsion) is seen in red; cell nuclei (nuclear stain) are seen in blue. NP message is in the cerebellum (A), cerebral 
cortex (B), hippocampus (C), and inferior olivary nucleus (G). In the cerebellum, hybridization is seen in Purkinje (P) and granule (g) neurons. In 
the hippocampus, there is strong hybridization i CA3, moderate in the dentate gyrus (DG), and low in CA1. There is also moderate hybridization 
in the medial habenula (MH). In the cortex, hybridization is strongest in layer 6 of the neocortex (shown in [B l and [D] for visual cortex) and layer 
2 of the olfactory cortex (F). Hybridization is only associated with gray matter. The lack of message in white matter (WM) is shown in (D) at the 
border of white matter and layer 6. A sense control of the same area is shown in (E). Nuclei staining is not shown for (F). (B), (C), (F), and (G) 
are composites of multiple images. Magnifications, 50x (A); 14x (B); 37x (C); 300x (D and E); 18x (F); 36x (G). 
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Table 1. Taipoxin-Mediated Glial Cell Death 
Taipoxin 
Concentration 0 1 nM 10 nM 100 nM 1 ~M 
NP ND ND ND ND 
rNP ND ND ND ND 
Eiuatel ND ND ND ND 
rSYT ND ND ND ND 
Taipoxin ND - - -  +- -  ++- 
Taipoxin-NP ND +- -  ++ ++ ND 
Taipoxin-Eluatel ND +--  +++ +++ ND 
Taipoxin-rNP ND +--  +++ +++ ND 
Taipoxin-rSyt ND - - -  +--  
ND, not determined; plus, glial cell death in 12 hr; minus, no glial cell 
death in 12 hr; rSYT, recombinant synaptotagmin residues 78-263. 
bellum and CA3 neurons of the hippocampus and moder- 
ate levels in neurons of the hilus, dentate gyrus, CA1, 
cerebral cortex, medial habenula, anterior hypothalamic 
nuclei, olfactory cortex, and inferior olivary nuclei. NP 
message is not found in gila in white or gray matter. It is 
noteworthy that NP is expressed at multiple levels of a 
specific neural pathway, including high expression in the 
cerebellar granule and Purkinje neurons and neurons in 
the inferior olivary nucleus. 
Antibodies to NP reveal that, contrary to the level of 
message, NP protein is rare. All four NP antibodies fail 
to detect NP in cortical or cerebellar homogenates, brain 
membranes, synaptic vesicles, or soluble protein frac- 
tions. The rarity of NP protein, as evidenced by its greater 
than 1000-fold purification on taipoxin columns, contrasts 
sharply with the abundance of NP message. The discrep- 
ancy between high message levels and the rarity of NP 
protein can be explained if it has a rapid turnover, as might 
be expected for a secreted protein. 
The homology of NP to other pentraxins uggests that 
NP is secreted. This is supported by our data that NP is 
glycosylated and has a cleaved signal peptide, as shown 
by the fact that deglycosylated NP and a bacterial recom bi- 
nant NP run at the same position on SDS-polyacrylamide 
gel electrophoresis (SDS-PAGE) gels. 
NP was isolated as a potential receptor for the snake 
venom toxin taipoxin. NP clearly has a high affinity for 
taipoxin, as it is greatly enriched (>1000-fold) on taipoxin 
columns. NP can also mediate taipoxin-induced glial cell 
death. This raises two possibilities for the taipoxin binding 
of NP. The first is that NP is a receptor for taipoxin, and 
after binding, NP-taipoxin is taken up into presynaptic ter- 
minals. This would require NP to be taken up presynapti- 
cally or to become associated with the presynaptic mem- 
brane. Alternatively, the binding of NP with taipoxin may 
represent a nonspecific mechanism to sequester toxins 
away from synapses. Giial cells are known to take up neu- 
rotoxins actively (Norenberg, 1994). If N P merely removes 
taipoxin, then there must be other high affinity binding 
proteins for taipoxin that are more directly involved with its 
action. Chromatography on taipoxin columns only reveals 
two major binding proteins, NP and a 49 kDa protein. The 
49 kDa protein is unlikely to be a receptor for taipoxin, as 
it is a reticular calcium-binding protein that appears to be 
present in all cells. The ability to transfect nonneuronal 
cells with NP cDNA should allow testing of whether NP 
is a receptor for taipoxin. It is interesting to compare NP 
with a recently identified muscle receptor for another Oxy- 
uranus scutellatus toxin, OS2 (Lambeau et al., 1994; Ishi- 
zaki et al., 1994). This receptor is an integral membrane 
protein that contains eight repeats of a carbohydrate rec- 
ognition domain. The receptor has sequence homology 
(29% overall identity) to a macrophage mannose receptor 
that mediates endocytosis of glycoproteins and bacteria, 
paralleling the homology of NP to pentraxins. 
A potential clue to the function of NP is that it is the first 
nervous system member of the pentraxin protein family. 
Because pentraxins are acute phase proteins whose ex- 
pression can be dramatically increased in response to in- 
fection or immunological challenge, it is probable that pen- 
traxins have an important function in inflammation or 
immune activation (Pepys and Baltz, 1983). CRP has been 
shown to bind at sites of tissue inflammation, bind phos- 
phorylcholine, and to activate the complement pathway 
(Volanakis, 1982; Mold et ai., 1982; Schwalbe, 1992). 
SAMP has been shown to bind to glycosaminoglycans, 
sugar s on lysosomal hydrolases, and acidic glycolipids 
(Loveless et al., 1992; Ying et al., 1993; Christner and 
Mortensen, 1994; Brown and Anderson, 1993). SAMP has 
also been shown to bind to chromatin and DNA (Hicks et 
al., 1992). Reflecting these diverse binding abilities, it has 
been suggested that the cellular function of both proteins 
is to bind bacteria, cell debris, or toxins (Gates and Rees, 
1990) and allow their uptake and perhaps presentation 
by macrophages (Pepys and Baltz, 1983). As such, the 
pentraxins may play a role in the clearance of extracellular 
material during immune responses. 
The neuronal expression of NP, its secretion, and its 
homology to SAMP and CRP suggest that NP may be 
involved in synaptic uptake, which could play an important 
role in synaptic remodeling. Formation, expansion, or 
elimination of synapses should require withdrawal of pre- 
and postsynaptic terminals, hydrolysis of synaptic connec- 
tions, and degradation of extracellular matrix (Mayford et 
al., 1992; Bailey and Kandel, 1993). Such activities hould 
generate synaptic debris to be removed from the synapse. 
CRP and SAM P have been hypothesized to fill a compara- 
ble role at sites of inflammation (Pepys and Baltz, 1983); 
NP could fulfill this role at the synapse. Further studies will 
determine whether and how regulation of NP expression is 
involved in synaptogenesis or plasticity in the developing, 
mature, and diseased brain. The molecular characteriza- 
tion of NP may also allow the identification of proteins that 
mediate its uptake. 
Experimental Procedures 
Materials 
~P-labeled nucleotides were obtained from DuPont-New England Nu- 
clear. Restriction and DNA modification enzymes were from New En- 
gland Biolabs and Promega. Sequenase was from United States Bio- 
chemical. Protein molecular weight standards were obtained from 
Bio-Rad; RNA and DNA standards from GIBCO-BRL. Peroxidase- 
labeled secondary antibodies were from Cappel. All other chemicals 
and proteins were of reagent grade and used without further purifi- 
cation. 
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Chromatography 
Taipoxin was isolated from crude Oxyuranus scutellatus venom by 
established procedures (Fohlman et al., 1976). This results in taipoxin 
that is greater than 98% pure. Toxin purity was assessed by silver 
staining to detect contaminating protein. Fractions used for affinity 
gels and experiments contained only the three taipoxin subunits. The 
activity of purified toxin was tested on hippocampal neurons (Zarei 
and Dani, 1994; Banker and Goslin, 1991). Taipoxin causes neuronal 
presynaptic terminal swelling and cell surface exposure of the lumenal 
domain of the synaptic vesicle protein synaptotagmin. For affinity gels, 
taipoxin was coupled to activated CH-Sepharose (Pharmacia) at pH 
7.0 according to standard protocol. 
For purification of NP, 20 rat brains were homogenized in 0.32 M 
sucrose, and membranes were pelleted at 40,000 x g for 45 min. 
Pellets were solubilized in 20 mM HEPES (pH 7.4), 1 mM EGTA, 1% 
Triton X-100 with 0.2 mM phenylmethylsulfonyl fluoride, 10 I~g/ml eu- 
peptin, and 10 p.g/ml pepstatin. Insoluble material was removed by a 
1 hr 150,000 x g spin. The supernatant was adjusted to 100 mM 
NaCI and 1 mM free calcium. The adjusted supernatant was run over 
taipoxin affinity column, washed extensively with 100 mM NaCI, 20 
mM HEPES, and 1 mM CaCI2, and eluted sequentially with 100 mM 
NaCI, 20 mM HEPES, 10 mM EDTA (E~) followed by 1 M NaCI, 20 
mM H EPES, 10 m M EDTA (E2). A preparation of 20 rat brains yielded 
approximately 10-50 ~g of NP. 
Amino Acid Sequencing of CNBr Fragments 
Individual proteins in the E1 fraction from taipoxin column chromatog- 
raphy were separated by ion exchange chomatography on a Mono-Q 
column (Pharmacia) with a 0-1 M NaCI gradient in 20 mM HEPES, 
1% CHAPS. Purified protein was cleaved with CNBr, and cleaved 
peptides were separated by SDS-PAGE, transferred to a solid support, 
and subjected to automated amino acid sequencing. 
cDNA Cloning and Sequencing 
cDNAs coding for determined peptide sequences were identified by 
hybridization to 32Polabeled egenerate oligonucleotides as previously 
described (Perin et al., 1988). cDNAs were sequenced by the dideoxy 
nucleotide chain termination method (Sanger et al., 1977), and se- 
quence data was searched against GenBank and SWISS-PROT data- 
bases. 
RNA Blotting 
Poly(A)÷-enriched RNA was electrophoresed, blotted onto nylon mem- 
branes, and hybridized with end-labeled antisense oligonucleotides or 
with uniformly 32P-labeled DNA probes corresponding to the antisense 
orientation as described (Perin et al., 1988). 
Bacterial Expression of NP 
Two pieces of NP cDNA were cloned into the bacterial expression 
vector pET11 d to produce recombinant NP (Studier at al., 1990; Perin 
et al., 1991). An Ncol-Bgl2 fragment (1430-1800) was cloned into 
Ncol-BH 1 cut pET1 ld to produce a recombinant protein incorporating 
residues 292-415. For a putatively full-length recombinant NP, an 
expression plasmid encoding residues 21-432 of NP was constructed 
by PCR using oligonucleotide primers complementary to the ends 
of the cDNA encoding this protein sequence according to previously 
described procedures (Perin et al,, 1990). 
Production of NP Antibodies 
Four antibodies were raised to NP. NP1 was raised against a bacterial 
recombinant protein incorporating residues 292-415. The second and 
fourth antibodies, NP2 (CAASVAAGGAEELRSN; residues 42-57 of 
NP) and NP4 (GATKWTFEACRQIN; residues 419-432, carboxyl- 
terminus of NP), were raised against synthetic peptides coupled to 
keyhole limpet hemocyanin, as described (Perin et al., 1990). NP3 
was raised against a bacterial recombinant protein incorporating resi- 
dues 21-432. 
Cell Culture 
Neurons were cultured according to Zarei et al. (Banker and Goslin, 
1991; Zarei and Dani, 1994). Glial cultures were prepared from these 
mixed cultures, except that neurons were killed by addition of gluta- 
mate and calcium chloride. 
In Situ Hybridization 
In situ hybridization was carried out essentially according to the proce- 
dure described by Wilkinson (1993). cRNA probes (antisense and 
sense) were prepared from NP cDNA in pBluescript using T7 and 
T3 polymerase; 800 bp antisense and sense probes were generated 
corresponding to the 3' untranslated region of NP. Hybridized sections 
were washed in graded concentrations of SSC, treated with ribo- 
nuclease A, dehydrated, dried, and covered with photographic emul- 
sion. Developed emulsions were dried and counterstained with 
Hoescht nuclear stain. 
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